0000000000130641

AUTHOR

Di Garbo V

showing 8 related works from this author

[Evaluation of resistance to activated protein C in myocardial infarction patients].

2001

It is known that resistance to activated protein C (APCR), often associated with a single point mutation (Arg506--Gln) in the coagulation factor V gene (factor V Leiden), is the most frequent inherited abnormality of blood coagulation. It plays a key role as pathogenetic factor of venous thromboembolism, but its association with an increased risk of arterial thrombosis is uncertain. Aim of the present study was to evaluate the prevalence of APCR in men, who suffered myocardial infarction more than 6 months earlier and without cardiovascular risk factors (hypercholesterolemia, smoking, diabetes, obesity and hypertension).The study was carried on 20 men aged65 years who have suffered myocardi…

MaleMyocardial InfarctionPrevalenceHumansMiddle AgedProtein C resistance myocardial infarctionActivated Protein C ResistanceMinerva cardioangiologica
researchProduct

Indium-111 Oxine Platelets Survival In Patients Suffering Of Cardiac And Cerebral Arteriosclerosis

2006

researchProduct

Effect of moderate Sicilian red wines comsuption on inflammatory biomarkers of atherosclerosis

2006

researchProduct

Relationship between body fat distribution and blood disorders in patients with visceral obesity with and without diabetes mellitus

2008

researchProduct

Effects of moderate consumption of sicilian red wines on some cardiovascular risk factors

2006

researchProduct

One-year atorvastatin treatment in hypercholesterolemic patients with or without carotid artery disease.

2006

Aim. Statins are the drugs of choice in heterozygous familial hypercholesterolemia (FH), which has a high risk of premature cardiovascular events including myocardial infarction, stroke, and surgical revascularization. Methods. A 1-year open-label study was conducted to test the efficacy and tolerability of Atorvastatin titrated to the target, in proven FH patients and to evaluate certain inflammatory parameters. One hundred and two FH patients (44 men and 58 women; mean age 58.7±3.6 years) were included in the study. After evaluation using the B-mode duplex scanning system of extracranial carotid arteries, the patients were divided into groups: Group 1 (15 men, 25 women) with carotid plaqu…

Blood PlateletsCarotid Artery DiseasesMaleTime FactorsCarotid Artery CommonHyperlipoproteinemia Type IIAtorvastatinHumansPyrrolesTriglyceridesApolipoproteins BApolipoprotein A-IAnticholesteremic AgentsCholesterol HDLFibrinogenCholesterol LDLMiddle Agedhs-CRPC-Reactive ProteinTreatment OutcomeHeptanoic AcidsPatient ComplianceFemaleHeterozygous familial hypercholesterolemiaHydroxymethylglutaryl-CoA Reductase InhibitorsCarotid arteryInternational angiology : a journal of the International Union of Angiology
researchProduct

Haemostatic and fibrinolytic abnormalities in obese patients and in patients with type 2 diabetes with metabolic syndrome

2006

researchProduct

One year atorvastatin treatment in patients with familial hypercholesterolrmia: effects on CRP and fibrinogen

2004

researchProduct